|Adachi S, Kawamoto T, Otsuka M, et al. Enteral vitamin B12 supplements reverse postgastrectomy B12 deficiency. Ann Surg. 2000; 232:199-201.
Anon. Vitamin B6 for melanoma. Medical World News. February 11, 1985.
Arsenio L, Bodria P, Magnati G, et al. Effectiveness of long-term treatment with pantethine inpatients with dyslipidemia. Clin Ther. 1986; 8:537-545.
Aybak M, Sermet A, Ayylidiz MO, Karakilcik AZ. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung. 1995; 45:1271-1273.
Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999; 19:357-377.
Battersby AR. How nature builds the pigments of life: The conquest of vitamin B12. Science. 1994; 264:1551-1557.
Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000; 23:1227-1231.
Bender DA. Non-nutritional uses of vitamin B6. Br J Nutrition. 1999; 81:7-20.
Bendich A, Cohen M. Vitamin B6 safety issues. Ann NY Acad Sci. 1990; 585:321-330.
Bernstein AL. Vitamin B6 in clinical neurology. Ann NY Acad Sci. 1990; 585:250-260.
Bernstein AL, Dinesen JS. Brief communication: effect of pharmacologic doses of vitamin B6 on carpal tunnel syndrome, electroencephalographic results, and pain. J Am Coll Nutr. 1993; 12:73-76.
Bertolini S, Donati C, Elicio N, et al. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children. Int J Clin Pharmacol Ther Toxicol. 1986; 24:630-637.
Bilski P, Li MY, Ehrenshaft M, et al. Vitamin B6 (pyridoxine) and its derivatives are efficient singlet oxygen quenchers and potential fungal antioxidants. Photochem Photobiol. 2000; 71:129-134.
Bon GB, Cazzolato G, Zago S, Avogaro P. Effects of pantothine on in vitro peroxidation of low density lipoproteins. Atherosclerosis. 1985; 57:99-106.
Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996; 54:382-390.
Branca D, Scutari G, Siliprandi N. Pantethine and pantothenate effect on the CoA content of rat liver. Internat J Vit Nutr Res. 1984; 54:211-216.
Butzkueven H, King JO. Nitrous oxide myelopathy in an abuser of whipped cream bulbs. J Clin Neurosci. 2000; 7:73-75.
Capuzzi DM, Guyton JR, Morgan JM, et al. Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am J Cardiol. 1998; 82(12A):74U-81U.
Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm ischemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988; 223:405-418.
Carmel R. Subtle cobalamin deficiency. Ann Intern Med. 1996; 124:338-339.
Carmel R, Gott PS, Waters CH, et al. The frequency of low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 1995; 54:245-253.
Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986; 8:1245-1255.
Cervantes-Laurean D, McElvaney NG, Moss J. Niacin. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:401-411.
Chang S-J. Vitamin B6 protects vascular endothelial injury by activated platelets. Nutr Res. 1999; 19:1613-1624.
Chojnowska-Jezierska J, Adamska-Dyniewska H. [Prolonged treatment with slow release nicotinic acid in patients with type II hyperlipidemia]. [Article in Polish]. Pol Arch Med Wewn. 1997; 98:391-399.
Choi S-W. Vitamin B12 deficiency: A new risk factor for breast cancer? Nutr Rev. 1999; 57:250-253.
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol. 1998; 55:1449-1455.
Colletti RB, Neufeld EJ, Roff NK, et al. Niacin treatment of hypercholesterolemia in children. Pediatrics. 1993; 92:78-82.
Dagnelie PC, van Staveren WA, van den Berg H. Vitamin B12 from algae appears not to be bioavailable. Am J Clin Nutr. 1991; 53:695-697.
Dakshinamurti, K, ed. Vitamin B6. New York, NY: The New York Academy of Sciences; 1990.
Delpre G, Stark P, Niv Y. Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation. Lancet. 1999; 354:740-741.
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
DiSorbo DM, Wagner R Jr, Nathanson L. In vivo and in vitro inhibition of B16 melanoma growth by vitamin B6. Nutr Cancer. 1985; 7:43-52.
Drennan CL, Huang S, Drummond JT, et al. How a protein binds B12: A 3.0 A X-ray structure of B12-binding domains of methionine synthase. Science. 1994; 266:1669-1674.
Elam MB, Hunninghake DB, Davis KB, et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: The ADMIT Study: A randomized trial. JAMA. 2000; 284:1263-1270.
Elia M. Oral or parenteral therapy for B12 deficiency (commentary). Lancet. 1998; 352:1721-1722.
Ellenbogen L. Vitamin B12. In: Machlin LJ, ed. Handbook of Vitamins. New York, NY: Marcel Dekker, Inc; 1984:497-547.
Ellis J, Folkers K, Watanabe T, et al. Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndrome. Am J Clin Nutr. 1979; 32:2040-2046.
Ellis JM, McCully KS. Prevention of myocardial infarction by vitamin B6. Res Commun Mol Pathol Pharmacol. 1995; 89:208-220.
Farquharson J, Adams JF. Conversion of hydroxo(aquo)co- balamin to sulfitocobalamin in the absence of light: a reaction of importance in the identification of the forms of vitamin B12, with possible clinical significance. Am J Clin Nutr. 1977; 30:1617-1622.
Fata FT, Herzlich BC, Schiffman G, Ast AL. Impaired antibody responses to pneumcoccal polysaccharide in elderly patients with low serum vitamin B12 levels. Ann Intern Med. 1996; 124:299-304.
Franzblau A, Rock CL, Werner RA, et al. The relationship of vitamin B6 status to median nerve function and carp
Funada U, Wada M, Kawata T, et al. Changes in CD4+CD8+/CD4-CD8+ ratio and humoral immune functions in vitamin B12-deficient rats. Int J Vitam Nutr Res. 2000; 70:167-171.
Goldberg A, Alagona P Jr, Capuzzi DM, et al. Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. Am J Cardiol. 2000; 85:1100-1105.
Gray DR, Morgan T, Chretian SD, Kashyap ML. Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med. 1994; 121:252-258.
Gregory JF III. Nutritional properties and significance of vitamin glycosides. Annu Rev Nutr. 1998; 18:277-296.
Gridley DS, Schultz TD, Stickney DR, Slater JM. In vivo and in vitro stimulation of cell-mediated immunity by vitamin B6. Nutr Res. 1988; 8:201-207.
Guilarte TR. Vitamin B6 and cognitive development: recent research findings from human and animal studies. Nutr Rev. 1993; 51:193-198.
Guyton JR. Effect of niacin on atherosclerotic cardiovascular disease. Am J Cardiol. 1998; 82:18U-23U.
Guyton JR, Blazing MA, Hagar J, et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Int Med. 2000; 160:1177-1184.
Harriman GR, Smith PD, Horne MK, et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1989; 149:2039-2041.
Heimburger DC, Alexander CB, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA. 1988; 259:1525-1530.
Henkin Y, Oberman A, Hurst DC. Niacin revisited: clinical observations on an important but underutilized drug. Am J Med. 1991; 91:239-246.
Higginbottom MC, Sweetman L, Nyhan WL. A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurological abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian. N Eng J Med. 1978; 299:317-323.
Houeto P, Hoffman JR, Imbert M, et al. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxycobalamin in cyanide poisoning. Lancet. 1995; 346:605-608.
Houston DK, Johnson MA, Nozza RJ, et al. Age-related hearing loss, vitamin B12, and folate in elderly women. Am J Clin Nutr. 1999; 69:564-571.
Illingworth DR, Stein EA, Mitchel YB, et al. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. Arch Intern Med. 1994; 154:1586-1595.
Jacobsen DW, Simon RA, Singh M. Sulfite oxidase deficiency and cobalamin protection in sulfite sensitive asthmatics. J Allergy Clin Immunol. 1984; 73(Suppl):135.
Johansson JO, Egberg N, Asplund-Carlson A, Carlson LA. Nicotinic acid treatment shifts the fibrinolytic balance favorably and decreases plasma fibrinogen in hypertriglyceridaemic men. J Cardiovasc Risk. 1997; 4:165-171.
Kaptan K, Beyan C, Ural AU, et al. Helicobacter pylori—is it a novel causative agent in Vitamin B12 deficiency? Arch Int Med. 2000; 160:1349-1353.
Khatami M. Role of pyridoxal phosphate/pyridoxine in diabetes. Inhibition of nonenzymatic glycosylation. Ann NY Acad Sci. 1990; 585:502-504.
King JM, Crouse JR, Terry JG, et al. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. Am J Med. 1994; 97:323-331.
Kozyraki R, Fyfe J, Kristiansen M, et al. The intrinsic factor-vitamin B12 receptor, cabilin, is a high-affinity apolipoprotein A-1 receptor facilitating endocytosis of high-density lipoprotein. Nat Med. 1999; 5:656-661.
Kristiansen M, Kozyraki R, Jacobsen C, et al. Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J Biol Chem. 1999; 274:20540-20544.
Kuzuminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998; 92:1191-1198.
Laine L, Ahnen D, McClain C, et al. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2000; 14:651-668.
Langdon FW. Nervous and mental manifestations of pre-pernicious anemia. JAMA. 1905; 45:1635-1638.
Laso Guzman FJ, Gonzalez-Buitrago JM, de Arriba F, et al. Carpal tunnel syndrome and vitamin B6. Klin Wochenschr. 1989; 67:38-41.
Leklem JE. Vitamin B6. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999; 413-421.
Lin S-J, Defossez P-A, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000; 289:2126-2128.
Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988; 318:1720-1728.
Lindstedt G. [Nitrous oxide can cause cobalamin deficiency. Vitamin B12 is a simple and cheap remedy]. [Article in Swedish]. Lakartidningen. 1999; 96:4801-4805.
Maksymowych AB, Robertson NM, Litwack G. Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study. Anticancer Research. 1993; 13:1925-1937.
McCaddon A, Kelly CL. Familial Alzheimer's disease and vitamin B12 deficiency. Age Ageing. 1994; 23:334-337.
McKenney JM, Proctor JD, Harris S, Chinchili VM. A comparison of the efficacy and toxic effects of sustained-vs immediate-release niacin in hypercholesterolemic patients. JAMA. 1994; 271:672-677.
Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy. Drugs Aging. 1998; 12:277-292.
Okada H, Moriwaki K, Kanno Y, et al. Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin. Nephrol Dial Transplant. 2000; 15:1410-1413.
Okawa M, Takahashi K, Egashira K, et al. Vitamin B12 treatment for delayed sleep phase syndrome. Psychiatry Clin Neurosci. 1997; 51:275-279.
Ostreicher DS. Vitamin B12 supplements as protection against nitrous oxide inhalation. NY State Dent J. 1994; 60:47-49.
Rader JI, Calvert RJ, Hathcock JN. Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med. 1992; 92:77-81.
Rall LC, Meydani SN. Vitamin B6 and immune competence. Nutr Rev. 1993; 51:217-225.
Rimland B, Calloway E, Dreyfus P. The effects of high doses of vitamin B6 on autistic children: a double-blind crossover study. Am J Psychiatry. 1978; 135:472-475.
Rosener M, Dichgans J. Severe combined degeneration of the spinal cord after nitrous oxide anaesthesia in a vegetarian. J Neurol Neurosurg Psychiatry. 1996; 60:354.
Saareks V, Mucha I, Sievi E, Riutta A. Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man. Pharmacol Toxicol. 1999; 84:274-280.
Salom IL, Silvis SE, Doscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scan J Gastroenterol. 1982; 17:129-131.
Scalabrino G, Tredici G, Buccellato FR, Manfridi A. Further evidence for the involvement of epidermal growth factor in the signaling pathway of vitamin B12 (cobalamin) in the rat central nervous system. J Neuropathol Exp Neurol. 2000; 59:808-814.
Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med. 1983; 309:445-448.
Schneider G, Kàck H, Lindquist Y. The manifold of vitamin B6 dependent enzymes. Structure. 2000; 8:R1-R6.
Sermet A, Aybak M, Ulak G, et al. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists. Arzneimittelforschung. 1995; 45:19-21.
Seto T, Inada H, Kobayashi N, et al. [Depression of serum pyridoxal levels in theophylline-related seizures]. [Article in Japanese]. No To Hattatsu. 2000; 32:295-300.
Shimizu T, Maeda S, Arakawa H, et al. Relation between theophylline and circulating vitamin levels in children with asthma. Pharmacology. 1996; 53:384-389.
Shimizu T, Maeda S, Mochizuki H, et al. Theophylline attenuates circulating vitamin B6 levels in children with asthma. Pharmacology. 1994; 49:392-397.
Spooner GR, Desai HB, Angel JF, et al. Using pyridoxine to treat carpal tunnel syndrome. Randomized control trial. Can Fam Physician. 1993; 39:2122-2127.
Stern F, Berner YN, Polyak Z, et al. [Nutritional status and vitamin B6 supplementation in the institutionalized elderly]. [Article in Hebrew]. Harefuah. 2000;
Stransky M, Rubin A, Lava NS, Lazaro RP. Treatment of carpal tunnel syndrome with vitamin B6: a double-blind study. South Med J. 1989; 82:841-842.
Stubbe J. Binding site of nature's most beautiful cofactor. Science. 1994; 266:1663-1664.
Sumner AE, Chin MM, Abrahm JL, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Int Med. 1996; 124:469-476.
Tato F, Vega GL, Grundy SM. Effects of crystalline nicotinic acid-induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase. Am J Cardiology. 1998; 81:805-807.
Trueblood NA, Ramasamy R, Wang LF, Schaefer S. Niacin protects the isolated heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2000; 279:H764-H771.
Tsalamandris C, Panagiotopoulos S, Sinha A, et al. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients. J Cardiovasc Risk. 1994; 1:231-239.
Ubbink JB, Hayward Vermaak WJ, Delport R, Serfontein WJ. The relationship between vitamin B6 metabolism, asthma, and theophylline therapy. Ann NY Acad Sci. 1990; 585:285-294.
van Asselt DZ, Blom HJ, Zuiderent R, et al. Clinical significance of low cobalamin levels in older hospital patients. Neth J Med. 2000; 57:41-49.
Vispé S, Yung TMC, Ritchot J, et al. A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc Natl Acad Sci USA. 2000; 97:9886-9891.
Wang W, Basinger A, Neese RA, et al. Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol Endocrinol Metab. 2000; 279:E50-E59.
Watanabe F, Katsura H, Takenaka S, et al. Pseudovitamin B12 is the predominant cobamide of an algal health food, spirulina tablets. J Agric Food Chem. 1999; 47:4736-4741.
Weir DG, Scott JM. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 1999; 55:669-682.
Weir DG, Scott JM. Vitamin B12 "Cobalamin." In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD; Williams and Wilkins; 1999:447-458.
Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B6 in the treatment of premenstrual syndrome: systemic review. Br Med J. 1999; 318:1375-1381.
Ziegler M. New Functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem. 2000; 267:1550-1564.
Carrara P, Matturri L, Galbussera M, et al. Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits. Atherosclerosis. 1984; 53:255-264.
Cighetti G, Del Puppo M, Paroni R, et al. Pantethine inhibits cholesterol and fatty acid syntheses and stimulates carbon dioxide formation in isolated rat hepatocytes. J Lipid Res. 1987; 28:152-161.
Clark JI, Livesey JC, Steele JE. Delay or inhibition of rat lens opacification using pantethine and WR-77913. Exp Eye Res. 1996; 62:75-84.
Congdon NT, West ST, Duncan DT, et al. The effect of pantethine and ultraviolet-B radiation on the development of lenticular opacity in the emory mouse. Curr Eye Res. 2000; 20:17-24.
Donati C, Barbi G, Cairo G, et al. Pantethine improves the lipid abnormalities of chronic hemodialysis patients: results of a multicenter clinical trial. Clin Nephrol. 1986; 25:70-74.
Donati C, Bertieri RS, Barbi G. [Pantethine, diabetes mellitus and atherosclerosis. Clinical study of 1045 patients]. [Article in Italian]. Clin Ter. 1989; 128:411-422.
Friberg G, Pande J, Ogun O, Benedek GB. Pantethine inhibits the formation of high-Tc protein aggregates in gamma B crystallin solutions. Curr Eye Res. 1996; 15:1182-1190.
Gaddi A, Descovich GC, Noseda G, et al. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia. Atherosclerosis. 1984; 50:73-83.
Galeone F, Scalabrino A, Giuntoli F, et al. The lipid-lowering effect of pantethine in hyperlipidemic patients: a clinical investigation. Curr Ther Res. 1983; 34:383-390.
Gensini GF, Prisco D, Rogasi PG, et al. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment. Int J Clin Pharm Res. 1985; 5:309-318.
Hayashi H, Kobayashi A, Terada H, et al. Effect of pantethine on action potential of canine papillary muscle during hypoxic perfusion. Jap Heart J. 1985; 26:289-296.
Hiramatsu N, Kishida T, Hamano T, Natake M. Effects of dietary pantethine levels on contents of fatty acids and thiobarbituric acid reactive substances in the liver of rats orally administered varying amounts of autoxidized linoleate. J Nutr Sci Vitaminol (Tokyo). 1991; 37:73-87.
Hoffman B, Lang A, Ostermann G, et al. Effect of pantethine on platelet functions in vitro. Curr Ther Res. 1987; 41:791-801.
Iida J, Nishimura K, Ukei S, Azuma I. Macrophage activation with pantethine and pantetheine-4'-phosphate. Int J Vitam Nutr Res. 1985; 55:405-411.
Kumerova AO, Silova AA, Utno Lia. [Effect of pantethine on post-heparin lipolytic activity and lipid peroxidation in the myocardium]. [Article in Russian]. Biull Eksp Biol Med. 1991; 111:33-35.
Maggi GC, Donati C, Criscuoli G. Pantethine: a physiological lipomodulating agent in the treatment of hyperlipidemias. Curr Ther Res. 1982; 32:380-386.
Nagiel-Ostaszewski I, Lau-Cam CA. Protection by pantethine, pantothenic acid and cystamine against carbon tetrachloride-induced hepatotoxicity in the rat. Res Commun Chem Pathol Pharmacol. 1990; 67:289-292.
Prisco D, Rogasi PG, Matucci M, et al. Effect of pantethine treatment on platelet aggregation and thromboxane A2 production. Curr Ther Res. 1984; 35:700-706.
Vecsei L, Alling C, Widerlov E. Comparative studies of intracerebroventricularly administered cysteamine and pantethine in different behavioral tests and on brain catechols in rats. Arch Int Pharmacodyn Ther. 1990; 305:140-151.
Watanabe A, Hobara BS, Kobayashi M, et al. Lowering of blood acetaldehyde but not ethanol concentrations by pantethine following alcohol ingestion: different effects in flushing and nonflushing subjects. Alcoholism: Clin Exper Res. 1985; 9:272-276.
Webster MJ. Physiological and performance responses to supplementation with thiamin and pantothenic acid derivatives. Eur J Appl Physiol. 1998; 77:486-491.
Wittwer CT, Graves CP, Peterson MA, et al. Pantethine lipomodulation: evidence for cysteamine mediation in vitro and in vivo. Atherosclerosis. 1987; 68:41-49.
Yoon SB, Kajiyama K, Ogura R. [Effect of pantethine on adriamycin-induced cardiotoxicity]. [Article in Japanese]. Kurume Igakkai Zasshi. 1982; 45:598-606.
Anon. Calcium pantothenate in arthritic conditions. A report from the General Practitioner Research Group. Practitioner. 1980; 224:208-211.
Aprahamian M, Dentinger A, Stock-Damge C, et al. Effects of supplemental pantothenic acid on wound healing: experimental study in rabbit. Am J Clin Nutr. 1985; 41:578-589.
Barton-Wright EC, Elliot WA. The pantothenic acid metabolism of rheumatoid arthritis. Lancet. 1963; 2:862-863.
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
Even PC, Decrouy A, Chinet A. Defective regulation of energy metabolism in mdx-mouse skeletal muscles. Biochem J. 1994; 304:649-654.
Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung. 2000; 50:659-663.
Hahn C, Roseler S, Fritzsche R, et al. Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis. 1993; 28:81-83.
Kapp A, Zeak-Kapp G. Effect of Ca-pantothenate on human granulocyte oxidative metabolism. Allerg Immunol (Leipz). 1991; 37:145-150.
Kehrl W, Sonnemann U. [Dexpanthenol nasal spray as an effective therapeutic principle for treatment of rhinitis sicca anterior]. [Article in German]. Laryngorhinootologie. 1998; 77:506-512.
Komar VI. [The use of pantothenic acid preparations in treating patients with viral hepatitis A]. [Article in Russian]. Ter Arkh. 1991; 63:58-60.
Kumerova AO, Utno LIa, Lipsberga ZE, Shkestere IIa. [Study of pantothenic acid derivatives as cardiac protectors in a model of experimental ischemia and reperfusion of the isolated heart]. [Article in Russian]. Biull Eksp Biol Med. 1992; 113:373-375.
Litoff D, Scherzer H, Harrison J. Effects of pantothenic acid supplementation on human exercise. Med Sci Sports Exercise. 1985; 17:287(Abstract 17).
Loftus EV Jr, Tremaine WJ, Nelson RA, et al. Dexpanthenol enemas in ulcerative colitis: a pilot study. Mayo Clin Proc. 1997; 72:616-620.
Moiseenok AG, Dorofeev BF, Omel'ianchik SN. [The protective effect of pantothenic acid derivatives and changes in the system of acetyl CoA metabolism in acute ethanol poisoning]. [Article in Russian]. Farmakol Toksikol. 1988; 51:82-86.
Nice C, Reeves AG, Brinck-Johnsen T, Noll W. The effects of pantothenic acid on human exercise capacity. J Sports Med. 1984; 24:26-29.
Plesofsky-Vig N. Pantothenic acid. In: Shils, ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore MD: Williams and Wilkins; 1999:423-432.
Rychlik M. Quantification of free and bound pantothenic acid in foods and blood plasma by a stable isotope dilution assay. J Agric Food Chem. 2000; 48:1175-1181.
achs M, Asskali F, Lanaros C, et al. [The metabolism of panthenol in patients with postoperative intestinal atony]. [Article in German]. Z Ernahrungswiss. 1990; 29:270-283.
Slyshenkov VS, Moiseenok AG, Wojtczak L. Noxious effects of oxygen reactive species on energy-coupling processes in Ehrlich ascites tumor mitochondria and the protection by pantothenic acid. Free Rad Biol Med. 1996; 20:793-800.
Slyshenkov VS, Omelyanchik SN, Moiseenok AG, et al. Panthenol protects rats against some deleterious effects of gamma radiation. Free Rad Biol Med. 1998; 24:894-899.
Slyshenkov VS, Rakowska M, Moiseenok AG, Wojtczak L. Pantothenic acid and its derivatives protect Ehrlich ascites tumor cells against lipid peroxidation. Free Rad Biol Med. 1995; 19:767-772.
Slyshenkov VS, Rakowska M, Wojtczak L. Protective effect of pantothenic acid and related compounds against permeabilization of Ehrlich ascites tumor cells by digitonin. Acta Biochim Pol. 1996; 43:407-410.
Vaxman F, Olender S, Lambert A, et al. Effect of pantothenic acid and ascorbic acid supplementation on human skin wound healing process. A double-blind, prospective and randomized trial. Eur Surg Res. 1995; 27:158-166.
Webster MJ. Physiological and performance responses to supplementation with thiamin and pantothenic acid derivatives. Eur J Appl Physiol. 1998; 77:486-491.
Weimann BI, Hermann D. Studies on wound healing: effects of calcium-D-pantothenate on the migration, proliferation and protein synthesis of human dermal fibroblasts in culture. Int J Vitam Nutr Res. 1999; 69:113-119.
Williams RJ. Biochemical Individuality. New York, NY: John Wiley and Sons, Inc; 1963.
Hermann H-P, Pieske B, Schwarzmü ller E, et al. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet. 1999; 353:1321-1323.
Ivy JL. Effect of pyruvate and dihydroxyacetone on metabolism and aerobic endurance capacity. Med Sci Sports Exer. 1998; 30:837-843.
Ivy JL, Cortez MY, Chandler RM, et al. Effects of pyruvate on the metabolism and insulin resistance of obese Zucker rats. Am J Clin Nutr. 1994; 59:331-337.
Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition. 1999; 15:337-340.
allet RT. Pyruvate: metabolic protector of cardiac performance. Proc Soc Exp Biol Med. 2000; 223:136-148
Mallet RT, Sun J. Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics. Cardiovasc Res. 1999; 42:149-161.
Matthys D, Van Coster R, Verhaaren H. Fatal outcome of pyruvate loading test in child with restrictive cardiomyopathy. Lancet. 1991; 338:1020-1021.
Robertson RJ, Stanko RT, Goss FL. Blood glucose extraction as a mediator of perceived exertion during prolonged exercise. Eur J Appl Physiol. 1990; 61:100-105.
Stanko RT, Arch JE. Inhibition of regain in body weight and fat with addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction. Int J Obes Relat Metab Disord. 1996; 20:925-930.
Stanko RT, Mullick P, Clarke MR, et al. Pyruvate inhibits growth of mammary adenocarcinoma 13762 in rats. Cancer Res. 1994; 54:1004-1007.
Stanko RT Reynolds HR, Hoyson R, et al. Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients. Am J Clin Nutr. 1994; 59:423-427.
Stanko RT, Reynolds HR, Lonchar KD, Arch JE. Plasma lipid concentrations in hyperlipidemic patients consuming a high-fat diet supplemented with pyruvate for 6 weeks. Am J Clin Nutr. 1992; 56:950-954.
Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a 4.25 MJ/d low-energy diet supplemented with pyruvate. Am J Clin Nutr. 1992; 56:630-635.
Anderson RA. Chromium, glucose intolerance and diabetes. J Amer Coll Nutr. 1998; 17:548-555.
Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998; 56:266-270.
Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate in rats. J Amer Coll Nutr. 1997; 16:273-279.
Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type II diabetes. Diabetes. 1997; 46:1786-1791.
Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother. 1998; 32:428-431.
Donaldson RM Jr, Barreras RF. Intestinal absorption of trace quantities of chromium. J Lab Clin Med. 1966; 68:484-493.
Guan X, Matte JJ, Ku PK, et al. High chromium yeast supplementation improves glucose tolerance in pigs by decreasing hepatic extraction of insulin. J Nutr. 2000; 130:1274-1279.
International Symposium on the Health Effects of Dietary Chromium. J Trace Elem Exp Med. 1999; 12:53-169.
Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999; 57:329-335.
Kaats GR, Blum K, Fisher JA, Adelman JA. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr Therap Res. 1996; 57:747-756.
Lukaski HC. Chromium as a supplement. Annu Rev Nutr. 1999; 19:279-302.
Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy. 1998; 18:860-862.
Merz W. Chromium in human nutrition: a review. J Nutr. 1993; 123:626-633.
Nielsen FH. Controversial chromium. Nutr Today. 1996; 31:226-233.
Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med. 1990; 152:41-45.
Porter DJ, Raymond LW, Anastasio GD. Chromium: Friend or foe? Arch Fam Med. 1999; 8:386-390.
Roeback JR Jr, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. Ann Int Med. 1991; 115:917-924.
Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium (III) tris (picolinate) cleaves DNA. Chem Res Toxicol. 1999; 12:483-487.
Stearns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J. 1995; 9:1650-1657.
Stearns DM, Wise JP Sr, Patierno SR, Wetterhahn KE. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 1995; 9:1643-1649.
Stoecker BJ. Chromium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:277-282.
Verhage AH, Cheong WK, Jeejeebhoy. Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induced syndromes. J Parenter Enter Nutr. 1996; 20:123-127.
Vincent J. The biochemistry of chromium. J Nutr. 2000; 130:715-718.
Vincent JB. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev. 2000; 58:67-72.
Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate [letter]. Ann Intern Med. 1997; 126:410.
Young PC, Turiansky GW, Bonner MW, Benson PM. Acute generalized exanthematous pustulosis induced by chromium picolinate. J Am Acad Dermatol. 1999; 41(5 pt 2):820-823.
Ahmad N, Mukhtar H. Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev. 1999; 57:78-83.
Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature. 1999; 398:381.
Demeule M, Brossard M, Pagé, M, et al. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta. 2000; 1478:51-60.
Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999; 70:1040-1045.
Dulloo AG, Seydoux J, Girardier L, et al. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000; 24:252-258.
Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea. Semin Urol Oncol. 1999; 17:70-76.
Haqqi TM, Anthony DD, Gupta S, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA. 1999; 96:4524-4529.
Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature. 1997; 387:561.
Kang WS, Lim IH, Yuk DY, et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Throm Res. 1999; 96:229-237.
L'Allemain G. [Multiple actions of EGCG, the main component of green tea]. [Article in French]. Bull Cancer. 1999; 86:721-724.
Li C, Lee M-J, Sheng S, et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol. 2000; 13:177-184.
Miura Y, Chiba T, Miura S, et al. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem. 2000; 11:216-222.
Mukhtar H, Katiyar SK, Agarwal R. Green tea and skin -- anticarcinogenic effects. J Invest Dermatol. 1994; 102:3-7.
Nakagawa K, Ninomiya M, Okubo T, et al. Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. J Agric Food Chem. 1999; 47:3967-3973.
Okushio K, Suzuki M, Matsumoto N, et al. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab Disp. 1999; 27:309-316.
Sachinidis A, Seul C, Seewald S, et al. Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett. 2000; 471:51-55.
Shi X, Ye J, Leonard SS, et al. Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr (VI)-induced DNA damage and Cr (IV)- or TPA-stimulated NF-Kappa B activation. Mol Cell Biochem. 2000; 206:125-132.
Suganuma M, Okabe S, Sueoka N, et al. Green tea and cancer chemoprevention. Mutation Res. 1999; 428:339-344.
Sugita-Konishi Y, Hara-Kudo Y, Amano F, et al. Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli. O157:H7. Biochem Biophys Acta. 1999; 1472:42-50.
Yang TTC, Koo MWL. Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation. Atherosclerosis. 2000; 148:67-73.
Antunes LMG, Araújo MCP, Darin JD'AC, Bianchi MdeLP. Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat Res. 2000; 465:131-137.
Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998; 4:376-383.
Barthelmy S, Vergnes L, Moynier M, et al. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol. 1998; 149:43-52.
Chan MM-Y. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995; 49:1551-1556.
Hellinger JA, Cohen CJ, Dugan ME, et al. Phase I/II randomized, open-label study of oral curcumin safety, and antiviral effects on HIV-RT PCR in HIV+ individuals. Third Conference on Retroviruses and Opportunistic Infections. Washington, DC; 1996: Abstract # 140.
Huang MT, Newmark HL, Fenkel K. Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl. 1997; 27:26-34.
Kang BY, Song YJ, Kim KM, et al. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. BR J Pharmacol. 1999:128:380-384.
Kawamori T, Lubet R, Steele VE, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999; 59:597-601.
Khopde SM, Priyadarsini KI, Guha SN, et al. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem. 2000; 64:503-509.
Kuo ML, Huang TS, Lin JK. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta. 1996; 1317:95-100.
Mazumder A, Raghavan K, Weinstein J, et al. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 1995; 49:1165-1170.
Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem. 2000; 275:10405-10412.
Pan M-H, Huang T-M, Lin J-K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Disp. 1999; 27:486-494.
Pandya U, Saini MK, Jin GF, et al. Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicol Lett. 2000; 115:195-204.
Park EJ, Jeon CH, Ko G, et al. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol. 2000; 52:437-440.
Ramiré z-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis. 1999; 147:371-378.
Sidhu GS, Mani H, Gaddipati JP, et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Rep Reg. 1999; 7:362-374.
Venkatesan N. Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci. 2000; 66:PL21-PL28.
Venkatesan N, Punithavathi D, Arumugam V. Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol. 2000; 129:231-234.
Zhang F, Altorki NK, Mestre JR, et al. Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 1999; 20:445-451.